Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Protocols / Breast Ref Applicant: Abbott-Arkansas Medical Sciences (2013)

Breast Ref Applicant: Abbott-Arkansas Medical Sciences (2013)

378

No involved investigator sites defined.

LPHA,and Periostin
Glycomics
Breast and Gynecologic Cancers Research

We are evaluating whether detection of a tumor-specific N-linked glycosylation known as B 1,6 branched N-glycan present on the glycoprotein periostin in breast cancer will be useful as a new biomarker for the detection of breast cancer in patient plasma and serum. We have completed an initial study using samples with known inavasive ductal breast carcinoma diagnosis and the results look very promising. Therefore, we would like to proceed with our analysis of this potential biomarker for breast cancer diagnosis by analyzing the blinded samples in breast reference set 1.

Validating B 1,6 as a biomarker for the early detection of breast cancer. Then continuing to validate L-PHA with the use of Breast Reference Set 2 samples.
The analysis for LPHA-periostin will be similar. In each case, data will be fit to the fixed-effects linear model yij = u + ai + Bj+ eij, wehre yij is the level, u is the grand mean, ai represent the pairing effect (age-matching), bj the tumor/normal effect,and eij random variation. Transformations of the response levels will be analyzed with the method of Box and Cox (1964); based on the preliminary data we anticipate the log transformation will be adequate. Basic plots of the transformed data will be analyzed for skewness and outliers.

There are currently no biomarkers annotated for this protocol.

No datasets are currently associated with this protocol.


2015 Steering Committee Meeting

The next EDRN Steering Committee Meeting will take place March 31st through April 2nd, 2015, in Atlanta, Georgia.

Announcement 02/12/2015

Please register for the 29th EDRN Steering Committee Meeting in Atlanta, GA from March 31-April 2, 2015. The registration page has information about booking hotel rooms and a draft agenda of the meeting.

Announcement